248 related articles for article (PubMed ID: 19704401)
41. A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.
Mathew BS; Fleming DH; Annapandian VM; Prasanna S; Prasanna CG; Chandy SJ; John GT
Ther Drug Monit; 2010 Apr; 32(2):136-40. PubMed ID: 20110849
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
Baraldo M; Isola M; Feruglio MT; Francesconi A; Franceschi L; Tursi V; Livi U; Furlanut M
Transplant Proc; 2005 Jun; 37(5):2240-3. PubMed ID: 15964387
[TBL] [Abstract][Full Text] [Related]
43. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
[TBL] [Abstract][Full Text] [Related]
44. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
Dupuis LL; Seto W; Teuffel O; Gibson P; Schultz KR; Doyle JD; Gassas A; Egeler RM; Sung L; Schechter T
Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
[TBL] [Abstract][Full Text] [Related]
45. Enteric-coated mycophenolate sodium provides higher mycophenolic acid predose levels compared with mycophenolate mofetil: implications for therapeutic drug monitoring.
Budde K; Tedesco-Silva H; Pestana JM; Glander P; Neumayer HH; Felipe CR; Machado PP; Sechaud R; Schmouder R
Ther Drug Monit; 2007 Jun; 29(3):381-4. PubMed ID: 17529899
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients.
Qiu K; Tian H; Wang W; Hu XP; Li XB; Gong LL; Luo W; Liu LH; Zhang XD; Yin H
Chin Med J (Engl); 2012 Dec; 125(23):4226-32. PubMed ID: 23217391
[TBL] [Abstract][Full Text] [Related]
47. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.
Langers P; Press RR; Inderson A; Cremers SC; den Hartigh J; Baranski AG; van Hoek B
Ther Drug Monit; 2014 Apr; 36(2):141-7. PubMed ID: 24081208
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J
Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332
[TBL] [Abstract][Full Text] [Related]
49. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil.
Julasareekul W; Eiam-Ong S; Bejraputra O; Seublinvong T
J Med Assoc Thai; 2003 Aug; 86(8):766-71. PubMed ID: 12948276
[TBL] [Abstract][Full Text] [Related]
51. Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.
de Winter BC; Neumann I; van Hest RM; van Gelder T; Mathot RA
Ther Drug Monit; 2009 Jun; 31(3):382-90. PubMed ID: 19363460
[TBL] [Abstract][Full Text] [Related]
52. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.
Arns W; Breuer S; Choudhury S; Taccard G; Lee J; Binder V; Roettele J; Schmouder R
Clin Transplant; 2005 Apr; 19(2):199-206. PubMed ID: 15740555
[TBL] [Abstract][Full Text] [Related]
53. Absorption characteristics of EC-MPS--an enteric-coated formulation of mycophenolic sodium.
Arns W; Gies M; Choi L; Zhu W; Cooper P; Yeh CM; Prasad P; Graf P; Schmouder R
Int J Clin Pharmacol Ther; 2006 Aug; 44(8):375-85. PubMed ID: 16961168
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.
Hummel M; Yonan N; Ross H; Miller LW; Sechaud R; Balez S; Koelle EU; Gerosa G;
Clin Transplant; 2007; 21(1):18-23. PubMed ID: 17302587
[TBL] [Abstract][Full Text] [Related]
55. Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.
Büchler M; Lebranchu Y; Bénéton M; Le Meur Y; Heng AE; Westeel PF; le Guellec C; Libert F; Hary L; Marquet P; Paintaud G
Clin Pharmacol Ther; 2005 Jul; 78(1):34-42. PubMed ID: 16003290
[TBL] [Abstract][Full Text] [Related]
56. Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
Yamaguchi K; Fukuoka N; Kimura S; Watanabe M; Tani K; Tanaka H; Sofue T; Kosaka S; Inui M; Kakehi Y; Houchi H
Biol Pharm Bull; 2013; 36(6):1036-9. PubMed ID: 23558676
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.
Le Guellec C; Büchler M; Giraudeau B; Le Meur Y; Gakoué JE; Lebranchu Y; Marquet P; Paintaud G
Eur J Clin Pharmacol; 2002 Jan; 57(11):805-11. PubMed ID: 11868803
[TBL] [Abstract][Full Text] [Related]
58. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
59. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
Teshima D; Maiguma T; Kaji H; Otsubo K; Kitagawa N; Okabe Y; Sugitani A; Tanaka M; Oishi R
J Clin Pharm Ther; 2008 Apr; 33(2):159-63. PubMed ID: 18315781
[TBL] [Abstract][Full Text] [Related]
60. Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy.
van Hest RM; Mathôt RA; Vulto AG; Le Meur Y; van Gelder T
Ther Drug Monit; 2004 Dec; 26(6):620-5. PubMed ID: 15570185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
